Federal Regulatory Tracker
Pending and Anticipated Regulations Impacting Medicaid, Medicare and Commercial Markets
November 22, 2022DownloadsDownload Article
In recent months and the coming year, there will be multiple opportunities to comment on the administration’s priorities for Medicare, Medicaid, and the commercial market, such as health equity and access, price transparency, mental health parity, and interoperability.
The Managed Care Year End Recap 2022 Read Now
FTI Consulting’s regulatory tracker highlights select anticipated or pending U.S. Department of Health and Human Services actions that may impact Medicare, Medicaid or the commercial market. The list is compiled from data in the Office of Information and Regulatory Affairs’ (OIRA) Spring 20221 Unified Regulatory Agenda (as the Fall 2022 regulatory agenda is not yet published) and the Federal Register.
Each Regulation Identifier Number (RIN) link directs users to the OIRA landing page for the regulatory action in question. If a link is provided under the “Action” column, the user will be directed to the primary source document in the Federal Register.
Most Popular Insights
- 10 Global Cybersecurity Predictions for 2024
- Global CFO Survey 2024
- Bridging the Gap Between Artificial Intelligence Implementation, Governance, and Democracy: An Operational and Regulatory Perspective
- The Power of Positive Paranoia: A Key Trait for Every CEO and General Counsel in 2024
- A Targeted Approach is Key to Implementing AI